[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:chromosome-8p":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Chromosome 8p",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07405801","A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer",[11],"Phase 2","RECRUITING","2026-08-26T02:19:21.761002Z","2026-05-05T02:43:29.297943Z"]